Kevin O Hicks

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Endothelial Cells

Endoplasmic Reticulum Stress

Top Venues

PLoS computational biology

Molecular cancer therapeutics

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lydia P Liew, Avik Shome, Way W Wong, Cho R Hong, Kevin O Hicks, Stephen M F Jamieson, Michael P Hay
Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers. Molecules (Basel, Switzerland) 28 (11) (2023)
Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, Ala Yaromina, Emily Liu, Damiënne Marcus, Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Xiaojing Lin, Zhe Fu, Sisira Kumara, Arthur Jochems, Amir Ashoorzadeh, Robert F Anderson, Kevin O Hicks, Matthew R Bull, Maria R Abbattista, Christopher P Guise, Sofie Deschoemaeker, Sophie Thiolloy, Arne Heyerick, Morwena J Solivio, Silvia Balbo, Jeff B Smaill, Jan Theys, Ludwig J Dubois, Adam V Patterson, Philippe Lambin
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506. Molecular cancer therapeutics 20 (12) (2021)
Xinjian Mao, Sarah McManaway, Jagdish K Jaiswal, Priyanka B Patel, William R Wilson, Kevin O Hicks, Gib Bogle
An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids. PLoS computational biology 14 (10) (2018)